ARCHIVES

ImClone Offered C225 Deal To Seven Firms Prior To BMS

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Herberman: Progress Made To Stabilize NSABP

September 9, 1994

Congress Passes Biomedical Research Authorization, Regular Appropriations Bill; NCI Gets $1.183 Billion

October 19, 1984

AACR President: Cancer Program ‘Threatened,’ Calls For Strategic Plan, More Extramural Input

December 6, 1991

DRCA Planning Described; New Cancer Control Conference Set

February 4, 1983

Technology Transfer Is Theme For 1990s, Broder Tells Writers; Laszio Offers Predictions On Treatment Advances

April 6, 1990

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

July 29, 2011